We also suggested that IL-22 treatment significantly ameliorated high-fat-diet-induced hepatocellular necrosis, injury, steatosis, ROS accumulation, and mitochondrial dysfunction via activation of AMPK-AKT-mTOR signaling pathways (Figure 6J-K, S8B and S9B). The gene discussed is AKT1; the disease is steatosis.